Different subcellular populations of L-type Ca 2+ channels exhibit unique regulation and functional roles in cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 376-387

  Best, Jabe M ^a   Kamp, Timothy J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Calcium channel; Calcium signaling; Cardiomyocyte; Microdomain; Subcellular localization

Indexed keywords

ADENYLATE CYCLASE; ATRIAL NATRIURETIC FACTOR; BETA 2 ADRENERGIC RECEPTOR; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; CALCIUM CHANNEL L TYPE; CALCIUM ION; CALMODULIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CHOLESTEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; OMEGA 3 FATTY ACID; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 2A; POTASSIUM CHANNEL KV1.5; PROTEIN KINASE C ALPHA; RYANODINE RECEPTOR; SIMVASTATIN; SNARE PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT; UNINDEXED DRUG;

ANTIARRHYTHMIC ACTIVITY; CALCIUM CURRENT; CALCIUM TRANSPORT; CARDIOMYOPATHY; CAVEOLA; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHANNEL GATING; DIET SUPPLEMENTATION; DRUG EFFECT; GENE MUTATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HUMAN; INTERNALIZATION; LIPID RAFT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STIMULUS SECRETION COUPLING; TRANSCRIPTION REGULATION;

ANIMALS; CALCIUM CHANNELS, L-TYPE; EXCITATION CONTRACTION COUPLING; HEART; HEART DISEASES; HUMANS; INTRACELLULAR SPACE; MEMBRANE MICRODOMAINS; MYOCYTES, CARDIAC; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84855983508     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.08.014     Document Type: Review

References (201)

1. Carl S.L., Felix K., Caswell A.H., Brandt N.R., Ball W.J., Vaghy P.L., et al. Immunolocalization of sarcolemmal dihydropyridine receptor and sarcoplasmic reticular triadin and ryanodine receptor in rabbit ventricle and atrium. J Cell Biol 1995, 129:673-682.
2. Sun X.H., Protasi F., Takahashi M., Takeshima H., Ferguson D.G., Franzini-Armstrong C. Molecular architecture of membranes involved in excitation-contraction coupling of cardiac muscle. J Cell Biol 1995, 129:659-671.
3. Takagishi Y., Rothery S., Issberner J., Levi A., Severs N.J. Spatial distribution of dihydropyridine receptors in the plasma membrane of guinea pig cardiac myocytes investigated by correlative confocal microscopy and label-fracture electron microscopy. J Electron Microsc (Tokyo) 1997, 46:165-170.
4. Takagishi Y., Yasui K., Severs N.J., Murata Y. Species-specific difference in distribution of voltage-gated L-type Ca(2+) channels of cardiac myocytes. Am J Physiol Cell Physiol 2000, 279:C1963-C1969.
5. Balijepalli R.C., Foell J.D., Hall D.D., Hell J.W., Kamp T.J. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci USA 2006, 103:7500-7505.
6. Balijepalli R.C., Kamp T.J. Caveolae, ion channels and cardiac arrhythmias. Prog Biophys Mol Biol 2008, 98:149-160.
7. Maxfield F.R. Plasma membrane microdomains. Curr Opin Cell Biol 2002, 14:483-487.
8. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
9. Parton R.G., Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007, 8:185-194.
10. 2+ channels. Annu Rev Cell Dev Biol 2000, 16:521-555.
11. Mikami A., Imoto K., Tanabe T., Niidome T., Mori Y., Takeshima H., et al. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 1989, 340:230-233.
12. 2+ channel mRNAs. J Mol Cell Cardiol 1997, 29:3035-3042.
13. 2+ channels. Cell 2000, 102:89-97.
14. 2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci USA 2003, 100:5543-5548.
15. 2+ channel in atrioventricular node automaticity. J Mol Cell Cardiol 2011, 50:194-202.
16. 2+ channels in cardiac and smooth muscles. Cardiovasc Res 2005, 68:197-203.
17. 2+ channel alpha 1c subunit isoform switching in failing human ventricular myocardium. J Mol Cell Cardiol 2000, 32:973-984.
18. Welling A., Kwan Y.W., Bosse E., Flockerzi V., Hofmann F., Kass R.S. Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity. Circ Res 1993, 73:974-980.
19. 2+ channels. Circ Res 1997, 81:526-532.
20. Singer D., Biel M., Lotan I., Flockerzi V., Hofmann F., Dascal N. The roles of the subunits in the function of the calcium channel. Science 1991, 253:1553-1557.
21. Kamp T.J., Pérez-García M.T., Marban E. Enhancement of ionic current and charge movement by coexpression of calcium channel beta 1A subunit with alpha 1C subunit in a human embryonic kidney cell line. J Physiol 1996, 492:89-96.
22. 2+ channels. J Biol Chem 1995, 270:30036-30044.
23. Foell J.D., Balijepalli R.C., Delisle B.P., Yunker A.M., Robia S.L., Walker J.W., et al. Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics 2004, 17:183-200.
24. Jay S.D., Sharp A.H., Kahl S.D., Vedvick T.S., Harpold M.M., Campbell K.P. Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides. J Biol Chem 1991, 266:3287-3293.
25. Chu P.J., Best P.M. Molecular cloning of calcium channel alpha(2)delta-subunits from rat atria and the differential regulation of their expression by IGF-1. J Mol Cell Cardiol 2003, 35:207-215.
26. Klugbauer N., Lacinová L., Marais E., Hobom M., Hofmann F. Molecular diversity of the calcium channel alpha2delta subunit. J Neurosci 1999, 19:684-691.
27. Bangalore R., Mehrke G., Gingrich K., Hofmann F., Kass R.S. Influence of L-type Ca channel alpha 2/delta-subunit on ionic and gating current in transiently transfected HEK 293 cells. Am J Physiol 1996, 270:H1521-H1528.
28. Jay S.D., Ellis S.B., McCue A.F., Williams M.E., Vedvick T.S., Harpold M.M., et al. Primary structure of the gamma subunit of the DHP-sensitive calcium channel from skeletal muscle. Science 1990, 248:490-492.
29. Klugbauer N., Dai S., Specht V., Lacinová L., Marais E., Bohn G., et al. A family of gamma-like calcium channel subunits. FEBS Lett 2000, 470:189-197.
30. Yang L., Katchman A., Morrow J.P., Doshi D., Marx S.O. Cardiac L-type calcium channel (Cav1.2) associates with {gamma} subunits. FASEB J 2011, 25:928-936.
31. Scriven D.R., Dan P., Moore E.D. Distribution of proteins implicated in excitation-contraction coupling in rat ventricular myocytes. Biophys J 2000, 79:2682-2691.
32. Gathercole D.V., Colling D.J., Skepper J.N., Takagishi Y., Levi A.J., Severs N.J. Immunogold-labeled L-type calcium channels are clustered in the surface plasma membrane overlying junctional sarcoplasmic reticulum in guinea-pig myocytes-implications for excitation-contraction coupling in cardiac muscle. J Mol Cell Cardiol 2000, 32:1981-1994.
33. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
34. Scriven D.R., Asghari P., Schulson M.N., Moore E.D. Analysis of Cav1.2 and ryanodine receptor clusters in rat ventricular myocytes. Biophys J 2010, 99:3923-3929.
35. Bers D.M. Excitation-contraction coupling and cardiac contractile force 2001, Kluwer Academic Press, Dordrecht, Netherlands. 2nd ed.
36. Orchard C.H., Pásek M., Brette F. The role of mammalian cardiac t-tubules in excitation-contraction coupling: experimental and computational approaches. Exp Physiol 2009, 94:509-519.
37. Kawai M., Hussain M., Orchard C.H. Excitation-contraction coupling in rat ventricular myocytes after formamide-induced detubulation. Am J Physiol 1999, 277:H603-H609.
38. Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 2000, 87:1095-1102.
39. Dart C. Lipid microdomains and the regulation of ion channel function. J Physiol 2010, 588:3169-3178.
40. Pike L.J. Rafts defined: a report on the Keystone Symposium on lipid rafts and cell function. J Lipid Res 2006, 47:1597-1598.
41. Echarri A., Muriel O., Del Pozo M.A. Intracellular trafficking of raft/caveolae domains: insights from integrin signaling. Semin Cell Dev Biol 2007, 18:627-637.
42. Calaghan S., White E. Caveolae modulate excitation-contraction coupling and beta2-adrenergic signalling in adult rat ventricular myocytes. Cardiovasc Res 2006, 69:816-824.
43. Cavalli A., Eghbali M., Minosyan T.Y., Stefani E., Philipson K.D. Localization of sarcolemmal proteins to lipid rafts in the myocardium. Cell Calcium 2007, 42:313-322.
44. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
45. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol Rev 2002, 54:431-467.
46. Song K.S., Scherer P.E., Tang Z., Okamoto T., Li S., Chafel M., et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996, 271:15160-15165.
47. Boulware M.I., Kordasiewicz H., Mermelstein P.G. Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons. J Neurosci 2007, 27:9941-9950.
48. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M., et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem 2001, 276:21425-21433.
49. Rothberg K.G., Ying Y.S., Kamen B.A., Anderson R.G. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 1990, 111:2931-2938.
50. Hill M.M., Bastiani M., Luetterforst R., Kirkham M., Kirkham A., Nixon S.J., et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008, 132:113-124.
51. Shibata E.F., Brown T.L., Washburn Z.W., Bai J., Revak T.J., Butters C.A. Autonomic regulation of voltage-gated cardiac ion channels. J Cardiovasc Electrophysiol 2006, 17(Suppl 1):S34-S42.
52. Head B.P., Insel P.A. Do caveolins regulate cells by actions outside of caveolae?. Trends Cell Biol 2007, 17:51-57.
53. Gabella G. Inpocketings of the cell membrane (caveolae) in the rat myocardium. J Ultrastruct Res 1978, 65:135-147.
54. Head B.P., Patel H.H., Roth D.M., Lai N.C., Niesman I.R., Farquhar M.G., et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 2005, 280:31036-31044.
55. Gerhardstein B.L., Gao T., Bünemann M., Puri T.S., Adair A., Ma H., et al. Proteolytic processing of the C terminus of the alpha(1C) subunit of L-type calcium channels and the role of a proline-rich domain in membrane tethering of proteolytic fragments. J Biol Chem 2000, 275:8556-8563.
56. Gao T., Cuadra A.E., Ma H., Bunemann M., Gerhardstein B.L., Cheng T., et al. C-terminal fragments of the alpha 1C (CaV1.2) subunit associate with and regulate L-type calcium channels containing C-terminal-truncated alpha 1C subunits. J Biol Chem 2001, 276:21089-21097.
57. Hulme J.T., Yarov-Yarovoy V., Lin T.W., Scheuer T., Catterall W.A. Autoinhibitory control of the CaV1.2 channel by its proteolytically processed distal C-terminal domain. J Physiol 2006, 576:87-102.
58. Schroder E., Byse M., Satin J. L-type calcium channel C terminus autoregulates transcription. Circ Res 2009, 104:1373-1381.
59. Colecraft H.M., Alseikhan B., Takahashi S.X., Chaudhuri D., Mittman S., Yegnasubramanian V., et al. Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cells. J Physiol 2002, 541:435-452.
60. 2+ signaling in the heart. J Cell Sci 2009, 122:1005-1013.
61. 2+ channels and mitochondria. Clin Exp Pharmacol Physiol 2010, 37:229-235.
62. 2+ channel in ventricular myocytes. J Mol Cell Cardiol 2009, 46:1016-1026.
63. Escobar M., Cardenas C., Colavita K., Petrenko N.B., Franzini-Armstrong C. Structural evidence for perinuclear calcium microdomains in cardiac myocytes. J Mol Cell Cardiol 2011, 50:451-459.
64. Bauer P.J. The local Ca concentration profile in the vicinity of a Ca channel. Cell Biochem Biophys 2001, 35:49-61.
65. 2+: molecular determinants and functional consequences. Physiol Rev 2006, 86:369-408.
66. 2+-dependent inactivation of L-type calcium channels. Neuron 1999, 22:549-558.
67. 2+ channels. J Biol Chem 2001, 276:30794-30802.
68. Haack J.A., Rosenberg R.L. Calcium-dependent inactivation of L-type calcium channels in planar lipid bilayers. Biophys J 1994, 66:1051-1060.
69. Langer G.A., Peskoff A. Calcium concentration and movement in the dyadic cleft space of the cardiac ventricular cell. Biophys J 1996, 70:1169-1182.
70. 2+ signalling. J Physiol 1997, 500:285-295.
71. 2+ channels and ryanodine receptors in rat ventricular myocytes. J Gen Physiol 1996, 108:435-454.
72. 2+ release in rat ventricular myocytes. J Physiol 2003, 552:415-424.
73. 2+ release from sarcoplasmic reticulum in guinea pig ventricular myocytes. Circ Res 1995, 76:102-109.
74. 2+ release at the T-tubules and surface membrane of rat ventricular myocytes. Circ Res 2004, 95:e1-e7.
75. 2+ channel inactivation in controlling heart excitation. Proc Natl Acad Sci USA 2002, 99:17185-17190.
76. Brette F., Orchard C. Resurgence of cardiac t-tubule research. Physiology (Bethesda) 2007, 22:167-173.
77. Isshiki M., Ying Y.S., Fujita T., Anderson R.G. A molecular sensor detects signal transduction from caveolae in living cells. J Biol Chem 2002, 277:43389-43398.
78. 2+ signaling. Cell Calcium 2005, 38:223-231.
79. 2+ channel cytoplasmic tails and its regulatory role. J Biol Chem 2003, 278:5021-5028.
80. 2+ channels. Proc Natl Acad Sci USA 2005, 102:11112-11117.
81. 2+ sparklet activity in arterial smooth muscle. J Gen Physiol 2006, 127:611-622.
82. 2+ channels and ryanodine receptors in heart cells. Nature 2001, 410:592-596.
83. 2+ channels during hypertension and Timothy syndrome. Circ Res 2010, 106:748-756.
84. 2+ channels work harder than others. J Gen Physiol 2010, 136:143-147.
85. Nichols C.B., Rossow C.F., Navedo M.F., Westenbroek R.E., Catterall W.A., Santana L.F., et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res 2010, 107:747-756.
86. George M.S., Pitt G.S. The real estate of cardiac signaling: location, location, location. Proc Natl Acad Sci USA 2006, 103:7535-7536.
87. 2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?. Sci Signal 2008, 1:pe31.
88. Maier L.S., Bers D.M. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J Mol Cell Cardiol 2002, 34:919-939.
89. Bers D.M., Guo T. Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci 2005, 1047:86-98.
90. Chen X., Nakayama H., Zhang X., Ai X., Harris D.M., Tang M., et al. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. J Mol Cell Cardiol 2011, 50:460-470.
91. Tsui J., Inagaki M., Schulman H. Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation. J Biol Chem 2005, 280:9210-9216.
92. Wang X., Tian Q.B., Okano A., Sakagami H., Moon I.S., Kondo H., et al. BAALC 1-6-8 protein is targeted to postsynaptic lipid rafts by its N-terminal myristoylation and palmitoylation, and interacts with alpha, but not beta, subunit of Ca/calmodulin-dependent protein kinase II. J Neurochem 2005, 92:647-659.
93. 2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chem 1997, 272:31203-31208.
94. Passier R., Zeng H., Frey N., Naya F.J., Nicol R.L., McKinsey T.A., et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest 2000, 105:1395-1406.
95. Deisseroth K., Heist E.K., Tsien R.W. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 1998, 392:198-202.
96. Wilkins B.J., De Windt L.J., Bueno O.F., Braz J.C., Glascock B.J., Kimball T.F., et al. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol 2002, 22:7603-7613.
97. 2+ channel activity and nuclear signaling. Neuron 2007, 55:261-275.
98. 2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc Natl Acad Sci USA 2008, 105:15623-15628.
99. Woodman S.E., Park D.S., Cohen A.W., Cheung M.W., Chandra M., Shirani J., et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002, 277:38988-38997.
100. Marcantoni A., Baldelli P., Hernandez-Guijo J.M., Comunanza V., Carabelli V., Carbone E. L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion. Cell Calcium 2007, 42:397-408.
101. Drews G., Krippeit-Drews P., Düfer M. Electrophysiology of islet cells. Adv Exp Med Biol 2010, 654:115-163.
102. 2+ channels. EMBO J 1996, 15:4100-4110.
103. Kobayashi T., Yamada Y., Fukao M., Tsutsuura M., Tohse N. Regulation of Cav1.2 current: interaction with intracellular molecules. J Pharmacol Sci 2007, 103:347-353.
104. Nishikimi T., Maeda N., Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006, 69:318-328.
105. Ruskoaho H., Toth M., Ganten D., Unger T., Lang R.E. The phorbol ester induced atrial natriuretic peptide secretion is stimulated by forskolin and Bay K8644 and inhibited by 8-bromo-cyclic GMP. Biochem Biophys Res Commun 1986, 139:266-274.
106. Schiebinger R.J. Calcium, its role in isoproterenol-stimulated atrial natriuretic peptide secretion by superfused rat atria. Circ Res 1989, 65:600-606.
107. Saito Y., Nakao K., Morii N., Sugawara A., Shiono S., Yamada T., et al. Bay K 8644, a voltage-sensitive calcium channel agonist, facilitates secretion of atrial natriuretic polypeptide from isolated perfused rat hearts. Biochem Biophys Res Commun 1986, 138:1170-1176.
108. McDonough P.M., Stella S.L., Glembotski C.C. Involvement of cytoplasmic calcium and protein kinases in the regulation of atrial natriuretic factor secretion by contraction rate and endothelin. J Biol Chem 1994, 269:9466-9472.
109. Ito T., Toki Y., Siegel N., Gierse J.K., Needleman P. Manipulation of stretch-induced atriopeptin prohormone release and processing in the perfused rat heart. Proc Natl Acad Sci USA 1988, 85:8365-8369.
110. 2+ environment on atrial natriuretic factor release. Am J Physiol 1989, 256:H1588-H1594.
111. Ruskoaho H., Vuolteenaho O., Leppäluoto J. Phorbol esters enhance stretch-induced atrial natriuretic peptide secretion. Endocrinology 1990, 127:2445-2455.
112. Wen J.F., Cui X., Ahn J.S., Kim S.H., Seul K.H., Kim S.Z., et al. Distinct roles for L- and T-type Ca(2+) channels in regulation of atrial ANP release. Am J Physiol Heart Circ Physiol 2000, 279:H2879-H2888.
113. Doubell A.F., Thibault G. Calcium is involved in both positive and negative modulation of the secretory system for ANP. Am J Physiol 1994, 266:H1854-H1863.
114. 2+ channel modulation. Pflugers Arch 1997, 434:362-372.
115. Page E., Upshaw-Earley J., Goings G.E. Localization of atrial natriuretic peptide in caveolae of in situ atrial myocytes. Circ Res 1994, 75:949-954.
116. Lang T., Bruns D., Wenzel D., Riedel D., Holroyd P., Thiele C., et al. SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J 2001, 20:2202-2213.
117. Chamberlain L.H., Burgoyne R.D., Gould G.W. SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc Natl Acad Sci U S A 2001, 98:5619-5624.
118. Salaün C., Gould G.W., Chamberlain L.H. Lipid raft association of SNARE proteins regulates exocytosis in PC12 cells. J Biol Chem 2005, 280:19449-19453.
119. Kawamura S., Miyamoto S., Brown J.H. Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J Biol Chem 2003, 278:31111-31117.
120. Maguy A., Hebert T.E., Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res 2006, 69:798-807.
121. Sen L., Bialecki R.A., Smith E., Smith T.W., Colucci W.S. Cholesterol increases the L-type voltage-sensitive calcium channel current in arterial smooth muscle cells. Circ Res 1992, 71:1008-1014.
122. Xiao Y.F., Sigg D.C., Leaf A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J Membr Biol 2005, 206:141-154.
123. Savelieva I., Camm J. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat Clin Pract Cardiovasc Med 2008, 5:30-41.
124. Sandesara C.M., Roodneshin H., Sbaity S., Olshansky B. Antiarrhythmic effects of statins in heart failure. Heart Fail Clin 2008, 4:187-200.
125. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1997, 94:4182-4187.
126. Vaquero M., Caballero R., Gómez R., Núñez L., Tamargo J., Delpón E. Effects of atorvastatin and simvastatin on atrial plateau currents. J Mol Cell Cardiol 2007, 42:931-945.
127. Goebel J., Logan B., Forrest K., Mieczkowski A., Roszman T.L., Wills-Karp M. Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor beta chain. J Investig Med 2005, 53:322-328.
128. Sánchez-Wandelmer J., Dávalos A., Herrera E., Giera M., Cano S., de la Peña G., et al. Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes. Biochim Biophys Acta 2009, 1788:1731-1739.
129. Ma D.W., Seo J., Davidson L.A., Callaway E.S., Fan Y.Y., Lupton J.R., et al. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J 2004, 18:1040-1042.
130. Li Q., Zhang Q., Wang M., Zhao S., Ma J., Luo N., et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007, 89:169-177.
131. Fuller M.D., Emrick M.A., Sadilek M., Scheuer T., Catterall W.A. Molecular mechanism of calcium channel regulation in the fight-or-flight response. Sci Signal 2010, 3:ra70.
132. Xiang Y., Kobilka B.K. Myocyte adrenoceptor signaling pathways. Science 2003, 300:1530-1532.
133. Singh K., Xiao L., Remondino A., Sawyer D.B., Colucci W.S. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 2001, 189:257-265.
134. Xiao R.P., Cheng H., Zhou Y.Y., Kuschel M., Lakatta E.G. Recent advances in cardiac beta(2)-adrenergic signal transduction. Circ Res 1999, 85:1092-1100.
135. Kuschel M., Zhou Y.Y., Spurgeon H.A., Bartel S., Karczewski P., Zhang S.J., et al. Beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation 1999, 99:2458-2465.
136. 2+/calmodulin kinase II. J Clin Invest 2003, 111:617-625.
137. Chesley A., Lundberg M.S., Asai T., Xiao R.P., Ohtani S., Lakatta E.G., et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res 2000, 87:1172-1179.
138. 2+ channel regulation in guinea-pig ventricular myocytes. J Physiol 2007, 580:765-776.
139. Calaghan S., Kozera L., White E. Compartmentalisation of cAMP-dependent signalling by caveolae in the adult cardiac myocyte. J Mol Cell Cardiol 2008, 45:88-92.
140. Kuschel M., Zhou Y.Y., Cheng H., Zhang S.J., Chen Y., Lakatta E.G., et al. G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem 1999, 274:22048-22052.
141. De Arcangelis V., Liu R., Soto D., Xiang Y. Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes. J Biol Chem 2009, 284:33824-33832.
142. 2+ channels in cardiac myocytes requires the distal carboxyl terminus of alpha1C but not serine 1928. Circ Res 2006, 98:e11-e18.
143. Lemke T., Welling A., Christel C.J., Blaich A., Bernhard D., Lenhardt P., et al. Unchanged beta-adrenergic stimulation of cardiac L-type calcium channels in Ca v 1.2 phosphorylation site S1928A mutant mice. J Biol Chem 2008, 283:34738-34744.
144. Levin K.R., Page E. Quantitative studies on plasmalemmal folds and caveolae of rabbit ventricular myocardial cells. Circ Res 1980, 46:244-255.
145. Scriven D.R., Klimek A., Asghari P., Bellve K., Moore E.D. Caveolin-3 is adjacent to a group of extradyadic ryanodine receptors. Biophys J 2005, 89:1893-1901.
146. Walden A.P., Dibb K.M., Trafford A.W. Differences in intracellular calcium homeostasis between atrial and ventricular myocytes. J Mol Cell Cardiol 2009, 46:463-473.
147. Schulson M.N., Scriven D.R., Fletcher P., Moore E.D. Couplons in rat atria form distinct subgroups defined by their molecular partners. J Cell Sci 2011, 124:1167-1174.
148. Jayasinghe I.D., Cannell M.B., Soeller C. Organization of ryanodine receptors, transverse tubules, and sodium-calcium exchanger in rat myocytes. Biophys J 2009, 97:2664-2673.
149. Brice N.L., Dolphin A.C. Differential plasma membrane targeting of voltage dependent calcium channel subunits expressed in a polarized epithelial cell line. J Physiol 1999, 515:685-694.
150. vβ association with caveolin-3 in the cardiomyocytes. Circulation 2008, 118:S_339. (Abstract).
151. Davies A., Kadurin I., Alvarez-Laviada A., Douglas L., Nieto-Rostro M., Bauer C.S., et al. The alpha2delta subunits of voltage-gated calcium channels form GPI-anchored proteins, a posttranslational modification essential for function. Proc Natl Acad Sci USA 2010, 107:1654-1659.
152. Brown D.A., Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68:533-544.
153. McEwen D.P., Li Q., Jackson S., Jenkins P.M., Martens J.R. Caveolin regulates kv1.5 trafficking to cholesterol-rich membrane microdomains. Mol Pharmacol 2008, 73:678-685.
154. Couchoux H., Bichraoui H., Chouabe C., Altafaj X., Bonvallet R., Allard B., et al. Caveolin-3 is a direct molecular partner of the Ca(v)1.1 subunit of the skeletal muscle L-type calcium channel. Int J Biochem Cell Biol 2011, 43:713-720.
155. Lee E., Marcucci M., Daniell L., Pypaert M., Weisz O.A., Ochoa G.C., et al. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science 2002, 297:1193-1196.
156. Hong T.T., Smyth J.W., Gao D., Chu K.Y., Vogan J.M., Fong T.S., et al. BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol 2010, 8:e1000312.
157. Lipsky R., Potts E.M., Tarzami S.T., Puckerin A.A., Stocks J., Schecter A.D., et al. Beta-adrenergic receptor activation induces internalization of cardiac Cav1.2 channel complexes through a beta-arrestin 1-mediated pathway. J Biol Chem 2008, 283:17221-17226.
158. Nichols B.J., Lippincott-Schwartz J. Endocytosis without clathrin coats. Trends Cell Biol 2001, 11:406-412.
159. Seebohm G., Strutz-Seebohm N., Birkin R., Dell G., Bucci C., Spinosa M.R., et al. Regulation of endocytic recycling of KCNQ1/KCNE1 potassium channels. Circ Res 2007, 100:686-692.
160. McEwen D.P., Schumacher S.M., Li Q., Benson M.D., Iñiguez-Lluhí J.A., Van Genderen K.M., et al. Rab-GTPase-dependent endocytic recycling of Kv1.5 in atrial myocytes. J Biol Chem 2007, 282:29612-29620.
161. Hardel N., Harmel N., Zolles G., Fakler B., Klöcker N. Recycling endosomes supply cardiac pacemaker channels for regulated surface expression. Cardiovasc Res 2008, 79:52-60.
162. Best J.M., Foell J.D., Buss C.R., Delisle B.P., Balijepalli R.C., January C.T., et al. Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channels. Am J Physiol Cell Physiol 2011, 300:C1023-C1033.
163. Mizuno F., Barabas P., Krizaj D., Akopian A. Glutamate-induced internalization of Ca(v)1.3L-type Ca(2+) channels protects retinal neurons against excitotoxicity. J Physiol 2010, 588:953-966.
164. Tsuruta F., Green E.M., Rousset M., Dolmetsch R.E. PIKfyve regulates CaV1.2 degradation and prevents excitotoxic cell death. J Cell Biol 2009, 187:279-294.
165. Antzelevitch C., Pollevick G.D., Cordeiro J.M., Casis O., Sanguinetti M.C., Aizawa Y., et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007, 115:442-449.
166. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ Res 2002, 91:517-524.
167. He J., Conklin M.W., Foell J.D., Wolff M.R., Haworth R.A., Coronado R., et al. Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure. Cardiovasc Res 2001, 49:298-307.
168. 2+ channels gaining respect in heart failure. Circ Res 2002, 91:451-453.
169. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
170. 2+ currents and human atrial fibrillation. Circ Res 1999, 85:428-436.
171. Gómez A.M., Valdivia H.H., Cheng H., Lederer M.R., Santana L.F., Cannell M.B., et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997, 276:800-806.
172. Litwin S.E., Zhang D., Bridge J.H. Dyssynchronous Ca(2+) sparks in myocytes from infarcted hearts. Circ Res 2000, 87:1040-1047.
173. Banfi C., Brioschi M., Wait R., Begum S., Gianazza E., Fratto P., et al. Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteomics 2006, 6:1976-1988.
174. 2+ release from the sarcoplasmic reticulum as subcellular mechanism of cardiac contractile dysfunction. J Mol Cell Cardiol 2011, 50:390-400.
175. Soeller C., Cannell M.B. Numerical simulation of local calcium movements during L-type calcium channel gating in the cardiac diad. Biophys J 1997, 73:97-111.
176. Napolitano C., Antzelevitch C. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res 2011, 108:607-618.
177. 2+ channel function during Timothy syndrome by ablation of an anchoring protein. Circ Res Jun 2011, 23. [Epub ahead of print].
178. Ackerman M.J., Mohler P.J. Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins. Circ Res 2010, 107:457-465.
179. Vatta M., Ackerman M.J., Ye B., Makielski J.C., Ughanze E.E., Taylor E.W., et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006, 114:2104-2112.
180. Hayashi T., Arimura T., Ueda K., Shibata H., Hohda S., Takahashi M., et al. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2004, 313:178-184.
181. Catteruccia M., Sanna T., Santorelli F.M., Tessa A., Di Giacopo R., Sauchelli D., et al. Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene. Neuromuscul Disord 2009, 19:779-783.
182. Rajab A., Straub V., McCann L.J., Seelow D., Varon R., Barresi R., et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet 2010, 6:e1000874.
183. 2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling. Cardiovasc Res 2008, 77:315-324.
184. O'Rourke B., Kass D.A., Tomaselli G.F., Kääb S., Tunin R., Marbán E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res 1999, 84:562-570.
185. Balijepalli R.C., Lokuta A.J., Maertz N.A., Buck J.M., Haworth R.A., Valdivia H.H., et al. Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure. Cardiovasc Res 2003, 59:67-77.
186. 2+ release in human failing cardiomyocytes. Cardiovasc Res 2004, 62:63-73.
187. Lyon A.R., MacLeod K.T., Zhang Y., Garcia E., Kanda G.K., Lab M.J., et al. Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proc Natl Acad Sci USA 2009, 106:6854-6859.
188. 2+ channel currents in failing ventricular myocytes. Am J Physiol Heart Circ Physiol 2011, 300:H978-H988.
189. 2+ release in myocytes from chronically ischemic myocardium. Circ Res 2008, 102:338-346.
190. 2+ channels in canine heart failure. Circ Res 2005, 97:566-573.
191. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982, 307:205-211.
192. Bristow M.R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., et al. Beta 1- and beta 2 adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986, 59:297-309.
193. Lohse M.J., Engelhardt S., Eschenhagen T. What is the role of beta adrenergic signaling in heart failure?. Circ Res 2003, 93:896-906.
194. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54:230-246.
195. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008, 1:62-73.
196. Yue L., Melnyk P., Gaspo R., Wang Z., Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999, 84:776-784.
197. Qi X.Y., Yeh Y.H., Xiao L., Burstein B., Maguy A., Chartier D., et al. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 2008, 103:845-854.
198. 2+-channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation. J Mol Cell Cardiol 2003, 35:437-443.
199. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004, 110:2651-2657.
200. Brundel B.J., Ausma J., van Gelder I.C., Van der Want J.J., van Gilst W.H., Crijns H.J., et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 2002, 54:380-389.
201. 2+ release in right atrial myocytes from experimental persistent atrial fibrillation. Circ Res 2009, 105:876-885.